HPV Vaccine Hesitancy Among Indiana Youth With Cancer and Blood Diseases

CompletedOBSERVATIONAL

Enrollment

176

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

July 14, 2021

Study Completion Date

July 5, 2022

Conditions

Human Papilloma Virus Vaccine Hesitancy

Interventions

BEHAVIORAL

Interviews

We will conduct a phone or virtual interview with patients with sickle cell disease or cancer, caregivers and their healthcare providers.

Trial Locations (1)

Riley Hospital for Children - Indiana University, Indianapolis

All Listed Sponsors

lead

Indiana University

OTHER

NCT04667702 - HPV Vaccine Hesitancy Among Indiana Youth With Cancer and Blood Diseases | Biotech Hunter | Biotech Hunter